Andrea Necchi: An Important Day for Patients with Bladder Cancer
Jul 31, 2025, 13:20

Andrea Necchi: An Important Day for Patients with Bladder Cancer

Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared on LinkedIn:

“Today marks an important day for patients with bladder cancer.

84% CR rate with TAR200 monotherapy in BCG unresponsive CIS

Sunrise1
FDA Priority Review

Here is the Journal of Clinical Oncology paper supporting these results.”

More posts featuring Bladder Cancer.